DE69725147D1 - Verfahren zur behandlung und vorbeugung von neurodegenerativen erkrankungen durch verabreichung von einem thiazolidin - Google Patents
Verfahren zur behandlung und vorbeugung von neurodegenerativen erkrankungen durch verabreichung von einem thiazolidinInfo
- Publication number
- DE69725147D1 DE69725147D1 DE69725147T DE69725147T DE69725147D1 DE 69725147 D1 DE69725147 D1 DE 69725147D1 DE 69725147 T DE69725147 T DE 69725147T DE 69725147 T DE69725147 T DE 69725147T DE 69725147 D1 DE69725147 D1 DE 69725147D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- administrating
- thiazolidine
- treating
- neurodegenerative diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2157196P | 1996-07-11 | 1996-07-11 | |
| US21571P | 1996-07-11 | ||
| PCT/US1997/011586 WO1998002160A1 (en) | 1996-07-11 | 1997-07-01 | Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69725147D1 true DE69725147D1 (de) | 2003-10-30 |
| DE69725147T2 DE69725147T2 (de) | 2004-07-22 |
Family
ID=21804973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69725147T Expired - Fee Related DE69725147T2 (de) | 1996-07-11 | 1997-07-01 | Verfahren zur behandlung und vorbeugung von neurodegenerativen erkrankungen durch verabreichung von einem thiazolidin |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5912259A (de) |
| EP (1) | EP0914122B1 (de) |
| JP (1) | JP2001508028A (de) |
| KR (1) | KR20000023683A (de) |
| CN (1) | CN1145481C (de) |
| AT (1) | ATE250416T1 (de) |
| AU (1) | AU726664B2 (de) |
| BR (1) | BR9710467A (de) |
| CA (1) | CA2255073A1 (de) |
| CO (1) | CO4940509A1 (de) |
| DE (1) | DE69725147T2 (de) |
| DK (1) | DK0914122T3 (de) |
| ES (1) | ES2205247T3 (de) |
| HK (1) | HK1020533A1 (de) |
| HR (1) | HRP970362A2 (de) |
| IL (1) | IL127487A (de) |
| NO (1) | NO990076D0 (de) |
| NZ (1) | NZ332763A (de) |
| PL (1) | PL331049A1 (de) |
| PT (1) | PT914122E (de) |
| TR (1) | TR199900040T2 (de) |
| WO (1) | WO1998002160A1 (de) |
| ZA (1) | ZA976142B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003104423A2 (en) * | 2002-06-11 | 2003-12-18 | Roy Ogle | Meningeal-derived stem cells |
| US20110104296A1 (en) * | 2008-05-08 | 2011-05-05 | Dipak Kumar Sarkar | Endorphin Therapy Compositions and Methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT83152B (pt) * | 1985-08-09 | 1989-03-30 | Lilly Co Eli | Processo para a preparacao de compostos di-t-butilfenoicos |
| EP0391644B1 (de) * | 1989-04-07 | 1996-06-19 | Eli Lilly And Company | Arylsubstituierte Rhodaninderivate |
| US5143928A (en) * | 1990-03-27 | 1992-09-01 | Warner-Lambert Company | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
| US5192753A (en) * | 1991-04-23 | 1993-03-09 | Mcgeer Patrick L | Anti-rheumatoid arthritic drugs in the treatment of dementia |
| ZA936492B (en) * | 1992-09-10 | 1995-03-02 | Lilly Co Eli | Compounds useful as hypoglycemic agents and for treating Alzheimer's disease. |
| WO1996022772A1 (en) * | 1995-01-23 | 1996-08-01 | Eli Lilly And Company | Method for treating multiple sclerosis |
| ATE301457T1 (de) * | 1995-06-12 | 2005-08-15 | Searle & Co | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
-
1997
- 1997-07-01 EP EP97933264A patent/EP0914122B1/de not_active Expired - Lifetime
- 1997-07-01 TR TR1999/00040T patent/TR199900040T2/xx unknown
- 1997-07-01 DE DE69725147T patent/DE69725147T2/de not_active Expired - Fee Related
- 1997-07-01 AT AT97933264T patent/ATE250416T1/de not_active IP Right Cessation
- 1997-07-01 WO PCT/US1997/011586 patent/WO1998002160A1/en active IP Right Grant
- 1997-07-01 JP JP50606698A patent/JP2001508028A/ja not_active Ceased
- 1997-07-01 AU AU36491/97A patent/AU726664B2/en not_active Ceased
- 1997-07-01 BR BR9710467A patent/BR9710467A/pt not_active Application Discontinuation
- 1997-07-01 IL IL12748797A patent/IL127487A/en not_active IP Right Cessation
- 1997-07-01 CA CA002255073A patent/CA2255073A1/en not_active Abandoned
- 1997-07-01 ES ES97933264T patent/ES2205247T3/es not_active Expired - Lifetime
- 1997-07-01 US US09/171,891 patent/US5912259A/en not_active Expired - Fee Related
- 1997-07-01 PL PL97331049A patent/PL331049A1/xx unknown
- 1997-07-01 NZ NZ332763A patent/NZ332763A/xx unknown
- 1997-07-01 CN CNB971960429A patent/CN1145481C/zh not_active Expired - Fee Related
- 1997-07-01 DK DK97933264T patent/DK0914122T3/da active
- 1997-07-01 PT PT97933264T patent/PT914122E/pt unknown
- 1997-07-03 HR HR60/021,571A patent/HRP970362A2/xx not_active Application Discontinuation
- 1997-07-10 ZA ZA9706142A patent/ZA976142B/xx unknown
- 1997-07-10 CO CO97038493A patent/CO4940509A1/es unknown
-
1999
- 1999-01-08 NO NO990076A patent/NO990076D0/no not_active Application Discontinuation
- 1999-01-09 KR KR1019997000140A patent/KR20000023683A/ko active IP Right Grant
- 1999-11-30 HK HK99105554A patent/HK1020533A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO4940509A1 (es) | 2000-07-24 |
| PL331049A1 (en) | 1999-06-21 |
| CN1223582A (zh) | 1999-07-21 |
| KR20000023683A (ko) | 2000-04-25 |
| DE69725147T2 (de) | 2004-07-22 |
| EP0914122A1 (de) | 1999-05-12 |
| BR9710467A (pt) | 1999-08-17 |
| PT914122E (pt) | 2003-12-31 |
| NO990076L (no) | 1999-01-08 |
| DK0914122T3 (da) | 2003-12-22 |
| EP0914122B1 (de) | 2003-09-24 |
| IL127487A0 (en) | 1999-10-28 |
| NO990076D0 (no) | 1999-01-08 |
| CN1145481C (zh) | 2004-04-14 |
| US5912259A (en) | 1999-06-15 |
| HRP970362A2 (en) | 1998-04-30 |
| ATE250416T1 (de) | 2003-10-15 |
| NZ332763A (en) | 2000-07-28 |
| ZA976142B (en) | 1998-02-02 |
| AU3649197A (en) | 1998-02-09 |
| ES2205247T3 (es) | 2004-05-01 |
| TR199900040T2 (xx) | 1999-04-21 |
| AU726664B2 (en) | 2000-11-16 |
| CA2255073A1 (en) | 1998-01-22 |
| HK1020533A1 (en) | 2000-05-12 |
| JP2001508028A (ja) | 2001-06-19 |
| IL127487A (en) | 2002-04-21 |
| WO1998002160A1 (en) | 1998-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60216830D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen | |
| ATE207352T1 (de) | Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen | |
| EA199800797A1 (ru) | Новые мостиковые циклические аминокислоты как фармацевтически применимые вещества | |
| ATE110958T1 (de) | Verwendung von sertralin zur behandlung verfrühter ejakulation. | |
| DE69835823D1 (de) | Verfahren zur behandlung von patienten die unter multipler sklerose leiden mit konsensus-interferon | |
| BG104686A (en) | Glycine transport inhibitors | |
| ATE320803T1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
| DE602004002394D1 (de) | (3-ä3-'(2,4-BIS-TRIFLUORMETHYL-BENZYL)-(5-ETHYL-PYRIMIDIN-2-YL)-AMINOÜ-PROPOXYü-PHENYL)-ESSIGSÄURE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN VON PPARS UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN | |
| DE59914712D1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
| WO1999048489A3 (en) | Melatonin for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders | |
| DE69423577D1 (de) | Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen. | |
| DE69530570D1 (de) | Verfahren zur behandlung von stoehrungen des menschlichen oder tierischen koerpers durch verabreichung von aminosaeuren | |
| DE69619187D1 (de) | Verfahren zur behandlung von motorischen defiziten | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| DE69725147D1 (de) | Verfahren zur behandlung und vorbeugung von neurodegenerativen erkrankungen durch verabreichung von einem thiazolidin | |
| DE69733169D1 (de) | Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs | |
| ATE304861T1 (de) | Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia | |
| DE60144493D1 (de) | Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen | |
| DE69626916T2 (de) | Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten | |
| ATE263573T1 (de) | Die verwendung von wachstumshormon zur herstellung eines medikaments zur behandlung der ischämischen hirnschädigung und demenz | |
| DE69620394T2 (de) | Verwendung von forskolin oder diese enthaltende extrakte zur herstellung eines medikaments für die behandlung von alkoholsucht | |
| DE69632117D1 (de) | Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten | |
| DE69909970D1 (de) | Verwendung von 2-amino-6-trifluoromethoxybenzothiazol zur herstellung eines arzneimittels zur vorbeugung oder behandlung von zerebellumkrankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |